258 related articles for article (PubMed ID: 30003954)
1. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting.
Ghaffari M; Dehghan G; Abedi-Gaballu F; Kashanian S; Baradaran B; Ezzati Nazhad Dolatabadi J; Losic D
Eur J Pharm Sci; 2018 Sep; 122():311-330. PubMed ID: 30003954
[TBL] [Abstract][Full Text] [Related]
2. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
[TBL] [Abstract][Full Text] [Related]
4. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
[TBL] [Abstract][Full Text] [Related]
5. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
Yellepeddi VK; Kumar A; Palakurthi S
Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo applications of 3D dendritic gold nanostructures.
Bolocan A; Mihaiescu DE; Meşterca AR; Spirescu VA; Tote EM; Mogoantă L; Mogoşanu GD; Grumezescu AM
Rom J Morphol Embryol; 2015; 56(3):915-24. PubMed ID: 26662123
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical and biomedical potential of surface engineered dendrimers.
Satija J; Gupta U; Jain NK
Crit Rev Ther Drug Carrier Syst; 2007; 24(3):257-306. PubMed ID: 17956215
[TBL] [Abstract][Full Text] [Related]
8. Bioreducible Peptide-Dendrimeric Nanogels with Abundant Expanded Voids for Efficient Drug Entrapment and Delivery.
Zhong D; Tu Z; Zhang X; Li Y; Xu X; Gu Z
Biomacromolecules; 2017 Nov; 18(11):3498-3505. PubMed ID: 28726393
[TBL] [Abstract][Full Text] [Related]
9. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of polyamidoamine dendrimer in targeting drug delivery system].
Ding RM; He H; Li J
Yao Xue Xue Bao; 2011 May; 46(5):493-501. PubMed ID: 21800534
[TBL] [Abstract][Full Text] [Related]
11. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
12. Dendrimers in the context of nanomedicine.
Dias AP; da Silva Santos S; da Silva JV; Parise-Filho R; Igne Ferreira E; Seoud OE; Giarolla J
Int J Pharm; 2020 Jan; 573():118814. PubMed ID: 31759101
[TBL] [Abstract][Full Text] [Related]
13. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
[TBL] [Abstract][Full Text] [Related]
15. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
16. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
17. Smart triblock dendritic unimolecular micelles as pioneering nanomaterials: Advancement pertaining to architecture and biomedical applications.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
J Control Release; 2019 Apr; 299():64-89. PubMed ID: 30797002
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
Giri S; Trewyn BG; Lin VS
Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
[TBL] [Abstract][Full Text] [Related]
19. Interplay of stimuli-responsiveness, drug loading and release for a surface-engineered dendrimer delivery system.
Liu R; Sun M; Liu X; Fan A; Wang Z; Zhao Y
Int J Pharm; 2014 Feb; 462(1-2):103-7. PubMed ID: 24374220
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
